Clinical Trial Update: Repeated Mesenchymal Stem Cell Therapy for Radiation-Induced Hyposalivation and Xerostomia in Head and Neck Cancer Survivors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating repeated mesenchymal stem cell therapy for radiation-induced hyposalivation and xerostomia in head and neck cancer surviv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Sjögren Syndrome
• Xerostomia

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Christian von Buchwald | Conditions: Xerostomia Due to Hyposecretion of Salivary Gland, Xerostomia Due to Radiotherapy | Phase 2 | Status: NOT_YET_RECRUITING